Can an Olive Polyphenol Rewire Muscle Energy in Older Men?

Study Overview

The paper, “Oleuropein Supplementation Increases Resting Skeletal Muscle Fractional Pyruvate Dehydrogenase Activity but Does Not Influence Whole-Body Metabolism: A Randomized, Double-Blind, and Placebo-Controlled Trial in Healthy, Older Males,” was published in The Journal of Nutrition in 2025 by Philippe J. M. Pinckaers and colleagues.

Forty healthy older men, mean age 60 ± 5 years, were randomized to placebo or 100 mg/day oleuropein supplied as 250 mg/day olive leaf extract for 36 days. The trial was double-blind and placebo-controlled. On day 1 and day 36, the investigators collected muscle and blood samples and used indirect calorimetry before and up to 120 minutes after supplement intake. They also tested leg strength and fatigue after 29 days.

The biological target was pyruvate dehydrogenase, or PDH. PDH helps decide whether carbohydrate-derived pyruvate enters mitochondrial oxidation. In plain English, it is one of the gatekeepers between “fuel is available” and “muscle mitochondria can burn it.” Preclinical work had suggested oleuropein could activate mitochondrial calcium uptake and improve energy metabolism. This human trial tested whether that signal survives contact with real people.

Key Findings: The Actual Numbers

The exposure check worked: plasma oleuropein metabolites increased after ingestion on both day 1 and day 36, with p < 0.001. That matters because a null trial is much easier to interpret when we know participants actually absorbed the compound.

The clearest positive result came after chronic supplementation. Resting fractional PDH activity was about 25% higher in the oleuropein group than placebo: 49 ± 14% versus 38 ± 10%, p = 0.016. Acute dosing did not significantly change PDH activity after 120 minutes, but RNA sequencing after acute oleuropein showed upregulation of oxidative-phosphorylation gene pathways with false-discovery-rate control below 0.05.

The trial also found a higher PDH-Serine293-phosphorylation signal after acute oleuropein compared with placebo, p = 0.015, and lower LDL cholesterol after chronic oleuropein, p = 0.043. But the major practical outcomes were negative: mitochondrial respiration, mitochondrial protein content, whole-body substrate metabolism, leg strength, and fatigue resistance were not meaningfully different between groups.

Mechanism: What Might Be Happening?

Oleuropein is not simply an “antioxidant sprinkle.” The mechanistic hypothesis is more specific. Preclinical evidence suggests oleuropein can interact with mitochondrial calcium handling. Calcium signals can activate dehydrogenases inside mitochondria, including PDH-related pathways, which helps determine how efficiently muscle shifts fuel into oxidative metabolism.

In this trial, the PDH signal suggests older human muscle may become a little more biochemically ready to oxidize carbohydrate at rest after repeated oleuropein exposure. That is interesting because aging is associated with reduced metabolic flexibility, impaired mitochondrial regulation, and declining muscle function. The gene-expression signal toward oxidative phosphorylation points in the same direction.

But the mechanism did not scale into a whole-body result over 36 days. That is the key scientific tension. A muscle biopsy can show altered enzyme activation while indirect calorimetry, strength tests, and fatigue protocols remain unchanged. Biology can move before performance moves — or the biopsy signal may simply be too small, too context-specific, or too short-lived to matter clinically.

Context: How It Compares With Olive Polyphenol Research

Most human olive-polyphenol research focuses on blood pressure, oxidized LDL, inflammation, glucose control, or vascular function. This paper sits in a smaller lane: muscle bioenergetics. It complements newer work showing olive-derived phenolics can produce measurable human biomarker changes, while also warning against overreach.

Compared with blood-pressure olive leaf extract trials, this study is weaker for immediate consumer action because it has no clear clinical endpoint win. Compared with EVOO dietary trials, it is cleaner mechanistically but less food-realistic: 100 mg/day isolated oleuropein from olive leaf extract is not the same thing as using extra virgin olive oil with dinner.

The result is still valuable. It narrows the claim: oleuropein may influence a skeletal-muscle energy enzyme in older men, but current evidence does not show improved strength, endurance, or everyday metabolic rate.

Limitations

• • Small and narrow sample: 40 healthy older men only; no women, frail older adults, or sarcopenia patients.
• • Short duration: 36 days may be too brief to change strength or fatigue outcomes.
• • Supplement, not EVOO: the intervention was olive leaf extract standardized to oleuropein, not extra virgin olive oil.
• • Mechanistic primary value: the strongest result was a biopsy enzyme-activity marker, not a clinical outcome.
• • Conflicts matter: several authors reported employment, research support, consulting relationships, or patents connected to Nestlé/Société des Produits Nestlé and related nutrition products.

Our Take

This is a good paper precisely because it does not give the easy headline. The PDH result is real enough to be worth attention: 49% versus 38% fractional activity, p = 0.016, is a coherent mechanistic signal. The design is also stronger than many supplement studies because it was randomized, double-blind, placebo-controlled, and included muscle biopsies rather than relying only on self-reported energy.

But as a consumer-health result, it is modest. If a supplement changes an enzyme but not strength, fatigue resistance, mitochondrial respiration, or whole-body metabolism, the right conclusion is “promising mechanism,” not “take this for muscle.”

My read: this study strengthens the idea that olive-family polyphenols are biologically active in humans beyond generic antioxidant language. It does not prove that oleuropein supplementation improves aging muscle function. For now, the best evidence-led olive strategy remains boring and powerful: replace lower-quality fats with high-quality EVOO, keep the diet Mediterranean, and let supplements earn stronger outcome data before treating them as essentials.

Reference

Pinckaers PJM, Petrick HL, Horstman AMH, et al. Oleuropein Supplementation Increases Resting Skeletal Muscle Fractional Pyruvate Dehydrogenase Activity but Does Not Influence Whole-Body Metabolism: A Randomized, Double-Blind, and Placebo-Controlled Trial in Healthy, Older Males. J Nutr. 2025;155(5):1373-1386. doi: 10.1016/j.tjnut.2025.02.015. PMID: 39993475. Trial registration: NCT05217433.